PortalWebmailToolbarShopping
 
Web  |  Images  |  News

 
Health
AP - 2 hours , 10 minutes ago
GlaxoSmithKline's controversial diabetes pill Avandia should be pulled from the U.K. market because of concerns that the drug can increase the risk of heart attacks, British drug regulators said Monday.
 
  • FDA relents from midodrine withdrawal plan
    AP - 6 hours , 33 minutes ago
    Federal regulators have backed off a plan to remove a Shire PLC low blood-pressure treatment from the market after warning in August that the drug has not been proven effective.
  • It's hard to predict which pills will best lower which patient's high blood pressure, but researchers are hunting ways to better personalize therapy -- perhaps even using a blood test.
  • WHO wants faster, more flu vaccine production
    AP - 13 hours , 8 minutes ago
    The vaccine used to contain the recent swine flu pandemic was effective, but health authorities will need to ramp up the speed and volume of production during the next global outbreak, a World Health Organization official said Monday.
  • A leading virus expert urged health authorities around the world Sunday to stay vigilant even though the recent swine flu pandemic was less deadly than expected, warning that bird flu could spark the next global outbreak.
  • A team of NASA doctors and engineers recommended Friday that Chilean authorities regulate the day-and-night sleep patterns of 33 trapped miners, boost their Vitamin D intake and phase in an exercise program as their nutrition improves.
  • Drug and medical device firm Abbott Laboratories said Friday it has abandoned plans to sell its vaccines unit, less than three months after exploring sales talks with rival companies.
  • Workers are paying a larger portion of their health insurance costs as businesses shift more of the burden to their employees to help ride out the economic downturn, an annual study shows.
  • 2010 COSTS: Total premiums for employer-sponsored health insurance climbed only 3 percent for family coverage and 5 percent for single coverage, according to a Kaiser Family Foundation and Health Research and Educational Trust report.
  • Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a yearslong federal investigation into its marketing of the top-selling, botulin-based drug.
  • Scientists are reporting a major advance in diagnosing tuberculosis: A new test can reveal in less than two hours, with very high accuracy, whether someone has the disease and if it's resistant to the main drug for treating it.
  • Editors of a top medical journal call Meridia "another flawed diet pill" and question whether it should stay on the market as a study shows it raises the risk of heart attack and stroke in people with heart problems.



Terms  |  Privacy  |  Company Info  |  Help  |  Advertise  |  FAQ |  Feedback
Copyright © 2010 The Associated Press. All rights reserved. The information contained in the AP News report may not be published, broadcast, rewritten or redistributed without the prior written authority of The Associated Press.

Copyright © 2010 Mail.com Media Corporation All rights reserved.
1.3.8.2